Healthy volunteers help test a better way to inject an experimental drug
NCT ID NCT04674826
First seen Apr 25, 2026 · Last updated May 20, 2026 · Updated 5 times
Summary
This study looked at how the drug tralokinumab behaves in the body when given as one injection versus two injections. It involved 101 healthy adults aged 18 to 55. The goal was to compare the drug levels and safety of the two injection methods, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
LEO Pharma Investigational Site
Berlin, 14050, Germany
Conditions
Explore the condition pages connected to this study.